Humacyte, Inc.
NASDAQ:HUMA
1.41 (USD) • At close September 8, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Omzet
| 0 | 0 | 1.565 | 1.263 | 1.491 | 6.187 |
| Kosten van de omzet
| 7.19 | 76.55 | 8.255 | 61.341 | 8.432 | 75.603 |
| Brutowinst
| -7.19 | -76.55 | -6.69 | -60.078 | -6.941 | -69.416 |
| Brutowinstmarge
| 0 | 0 | -4.275 | -47.568 | -4.655 | -11.22 |
| Onderzoek- en ontwikkelingskosten
| 88.599 | 76.55 | 63.26 | 61.341 | 54.078 | 75.603 |
| Algemene en administratieve kosten
| 25.799 | 23.392 | 22.883 | 21.13 | 12.013 | 16.275 |
| Verkoop- en marketingkosten
| 0 | -3.002 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 25.799 | 20.39 | 22.883 | 21.13 | 12.013 | 16.275 |
| Overige kosten
| -7.19 | -73.443 | -8.255 | -61.341 | -8.432 | -75.603 |
| Bedrijfskosten
| 107.208 | 23.497 | 77.888 | 21.13 | 57.659 | 16.275 |
| Bedrijfsresultaat
| -114.398 | -100.047 | -84.578 | -81.208 | -64.6 | -85.691 |
| Bedrijfsresultaat ratio
| 0 | 0 | -54.043 | -64.298 | -43.327 | -13.85 |
| Totaal overige inkomsten en kosten netto
| -34.303 | -10.729 | 72.613 | 54.731 | -1.924 | 0.269 |
| Inkomen voor belasting
| -148.701 | -110.776 | -11.965 | -26.477 | -66.524 | -85.422 |
| Inkomen voor belasting ratio
| 0 | 0 | -7.645 | -20.964 | -44.617 | -13.807 |
| Belastingkosten
| 0 | 0 | 0 | 0 | 0 | 0 |
| Nettowinst
| -148.701 | -110.776 | -11.965 | -26.477 | -66.524 | -85.422 |
| Nettowinstmarge
| 0 | 0 | -7.645 | -20.964 | -44.617 | -13.807 |
| WPA (Winst Per Aandeel)
| -1.26 | -1.07 | -0.12 | -0.66 | -5.52 | -4.25 |
| Verwaterde WPA
| -1.26 | -1.07 | -0.12 | -0.66 | -5.52 | -4.25 |
| EBITDA
| -132.234 | -96.458 | -76.368 | -72.967 | -56.249 | -78.942 |
| EBITDA ratio
| 0 | 0 | -48.797 | -57.773 | -37.726 | -12.759 |